Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 7 of 7 clinical reviews.
Evidence-based guide on combining alpha-lipoic acid supplements with Vyleesi (bremelanotide) for HSDD, covering interaction mechanisms, dose-separation strategies, and monitoring recommendations.
Read clinical reviewClinical review of ashwagandha and Vyleesi (bremelanotide) interactions, covering pharmacokinetic and pharmacodynamic overlap, dose-separation guidance, monitoring, and safety for premenopausal women.
Read clinical reviewClinical review of berberine and Vyleesi (bremelanotide) interactions, covering CYP3A4 inhibition, blood pressure effects, dose-separation strategies, and monitoring recommendations.
Read clinical reviewEvidence-based guide on ginseng and Vyleesi (bremelanotide) interactions, covering pharmacokinetic and pharmacodynamic concerns, dose-separation strategies, and monitoring recommendations.
Read clinical reviewA clinical review of the melatonin and Vyleesi (bremelanotide) interaction, covering pharmacokinetic and pharmacodynamic pathways, dose-separation timing, blood pressure effects, and monitoring guidance.
Read clinical reviewEvidence-based analysis of quercetin and Vyleesi (bremelanotide) coadministration, covering CYP3A4 interaction potential, pharmacokinetic and pharmacodynamic considerations, dose-separation strategy, and monitoring recommendations.
Read clinical reviewA clinical review of the resveratrol and Vyleesi (bremelanotide) interaction, covering CYP3A4 concerns, estrogenic overlap, blood pressure effects, dose-separation strategies, and monitoring guidance.
Read clinical review